| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 03/02/1999 | US5876718 Using antibodies which bind to protein |
| 03/02/1999 | US5876717 Prevent rejection of organ transplantation and also to cure autoimmune diseases. |
| 03/02/1999 | US5876716 Aids therapy |
| 03/02/1999 | US5876713 Glutamine: fructose-6-phosphate amidotransferase, its production and use |
| 03/02/1999 | US5876712 Immune reactivity to HER-2/neu protein for diagnosis and treatment of malignancies in which the HER-2/neu oncogene is associated |
| 03/02/1999 | US5876710 Drug delivery; using a brominated benzamide compound |
| 03/02/1999 | US5876708 Allogeneic and xenogeneic transplantation |
| 03/02/1999 | US5876691 Screening a bacteriophage library; diagnosis of colorectal tumors |
| 03/02/1999 | CA2242315A1 Mecb |
| 03/02/1999 | CA2242252A1 Dexb |
| 03/02/1999 | CA2241417A1 Novel ffh |
| 03/02/1999 | CA1340417C Monoclonal antibodies specific to human epidermal growth factor receptor and therapeutic methods employing same |
| 03/02/1999 | CA1340414C Inactivation of human immunodeficiency virus (hiv) in protein-containing solutions by phenols |
| 03/01/1999 | CA2242311A1 Novel compounds |
| 02/28/1999 | CA2241427A1 Novel pyrr homolog |
| 02/28/1999 | CA2241424A1 Novel ftsy |
| 02/28/1999 | CA2241420A1 Novel folc |
| 02/28/1999 | CA2241400A1 Ftsy |
| 02/27/1999 | CA2233681A1 Novel div1b |
| 02/26/1999 | CA2241410A1 Pth |
| 02/25/1999 | WO1999009412A1 Functional fragments of hiv-1 vpr protein and methods of using the same |
| 02/25/1999 | WO1999009216A2 Highly sensitive multimeric nucleic acid probes |
| 02/25/1999 | WO1999009206A1 Methods for using granzymes and binding molecules thereof for treating diseases characterized by abnormal apoptosis |
| 02/25/1999 | WO1999009199A2 Elongation factor-2 kinase (ef-2 kinase) and methods of use therefor |
| 02/25/1999 | WO1999009198A1 Human nodal and lefty homologues |
| 02/25/1999 | WO1999009197A1 Methods and compositions for cloning nucleic acid molecules |
| 02/25/1999 | WO1999009185A1 Plasminogen activator with improved zymogenity |
| 02/25/1999 | WO1999009184A1 Plasminogen activator with enhanced zymogenic power and reduced fibrin linking |
| 02/25/1999 | WO1999009182A2 Rab proteins |
| 02/25/1999 | WO1999009181A1 Human stress-activated protein kinase, skk4 |
| 02/25/1999 | WO1999009178A1 Functional characterization of the c-c chemokine-like molecules encoded by molluscum contagiosum virus types 1 and 2 |
| 02/25/1999 | WO1999009172A1 Method for identifying and locating expressed epil peptides, coded by the insl4 gene and their uses |
| 02/25/1999 | WO1999009171A1 Ubc7-like ubiquitin-conjugating enzyme |
| 02/25/1999 | WO1999009170A1 High affinity immunoglobulin e receptor-like protein |
| 02/25/1999 | WO1999009168A1 Testis-specific transcription factor zgcl-1 |
| 02/25/1999 | WO1999009167A1 Porcine mhc class i genes and uses thereof |
| 02/25/1999 | WO1999009164A1 Coding sequence haplotypes of the human brca2 gene |
| 02/25/1999 | WO1999009162A2 Delayed progression to aids by a missense allele of the ccr2 gene |
| 02/25/1999 | WO1999009161A1 Pancreas-derived plasminogen activator inhibitor |
| 02/25/1999 | WO1999009157A1 POLYPEPTIDE HAVING A GTPase REGULATOR ACTIVITY, NUCLEIC ACIDS CODING THEREFOR AND THEIR USE IN DIAGNOSTICS AND THERAPY |
| 02/25/1999 | WO1999009156A2 Protease-related protein |
| 02/25/1999 | WO1999009155A1 70 human secreted proteins |
| 02/25/1999 | WO1999009154A2 Novel hiv-specific synthetic oligonucleotides and methods of their use |
| 02/25/1999 | WO1999009152A1 Human frezzled-like protein |
| 02/25/1999 | WO1999009149A1 Three-dimensional polymer matrices |
| 02/25/1999 | WO1999009147A1 Truncated platelet-activating factor acetylhydrolase |
| 02/25/1999 | WO1999009146A1 Human serum inducible kinase (snk) |
| 02/25/1999 | WO1999009145A1 Identification of sortase gene |
| 02/25/1999 | WO1999009140A1 Nucleic acid sequences encoding capsaicin receptor and capsaicin receptor-related polypeptides and uses thereof |
| 02/25/1999 | WO1999009065A1 Peptide with radio protective effect |
| 02/25/1999 | WO1999009064A1 Epitope-bearing major histocompatibility complex class ii element/immunoglobulin chimeric molecules |
| 02/25/1999 | WO1999009063A1 Interleukin-18 binding proteins, their preparation and use |
| 02/25/1999 | WO1999009062A1 Cell chemotactic factor (cctf) originating in mammalian tooth precement or cement, method for purifying the same, and novel connective tissue adhesion promoters containing the same as the active ingredient |
| 02/25/1999 | WO1999009061A1 Secreted proteins |
| 02/25/1999 | WO1999009057A2 Hybrid tetanus toxoid proteins that migrate retrogradely and transynaptically into the cns |
| 02/25/1999 | WO1999009056A1 Inhibition of hiv-1 replication using d-amino acid peptides |
| 02/25/1999 | WO1999009055A2 Interferon-gamma-binding molecules for treating septic shock, cachexia, immune diseases and skin disorders |
| 02/25/1999 | WO1999009054A2 Peroxisome-associated polypeptide, nucleotide sequence encoding said polypeptide and their uses in the diagnosis and/or the treatment of lung injuries and diseases, and of oxidative stress-related disorders |
| 02/25/1999 | WO1999009053A1 Phenethylamine derivatives |
| 02/25/1999 | WO1999009052A1 Chemical modification of proteins to improve biocompatibility and bioactivity |
| 02/25/1999 | WO1999009051A1 Method for the induction of proteins with therapeutic effect |
| 02/25/1999 | WO1999009049A1 Hypoxia-regulated genes |
| 02/25/1999 | WO1999009046A1 Hypoxia-regulated genes |
| 02/25/1999 | WO1999009045A1 Antisense and antigene therapeutics with improved binding properties and methods for their use |
| 02/25/1999 | WO1999008729A1 Loading and release of water-insoluble drugs |
| 02/25/1999 | WO1999008718A2 Bioresorbable compositions for implantable prostheses |
| 02/25/1999 | WO1999008707A1 Preventives and/or remedies for systemic lupus erythematosus containing anti-il-6 receptor antibody as the active ingredient |
| 02/25/1999 | WO1999008703A1 Anti-viral treatment with pertussis toxin b oligomer |
| 02/25/1999 | WO1999008702A1 Methods for treatment of patients afflicted wih multiple sclerosis using consensus interferon |
| 02/25/1999 | WO1999008701A1 Complexes of apolipoprotein e and ciliary neurotrophic factor (cntf) and methods of use |
| 02/25/1999 | WO1999008700A1 pRb2/p130 PEPTIDE INHIBITORS OF cdk2 KINASE ACTIVITY |
| 02/25/1999 | WO1999008699A1 Growth hormone secretagogues |
| 02/25/1999 | WO1999008698A1 Antigenic peptides of streptokinase |
| 02/25/1999 | WO1999008697A1 Treatment of congestive heart failure with growth hormone secretagogues |
| 02/25/1999 | WO1999008696A1 METHODS FOR DETERMINING CELL RESPONSES THROUGH EphB RECEPTORS |
| 02/25/1999 | WO1999008695A1 FLUORESCENT AMYLOID Aβ PEPTIDES AND USES THEREOF |
| 02/25/1999 | WO1999008681A1 Inducing neurotransmitter and neuropeptide activity |
| 02/25/1999 | WO1999008677A1 METHODS FOR INHIBITING DETRIMENTAL SIDE-EFFECTS DUE TO GnRH OR GnRH AGONIST ADMINISTRATION |
| 02/25/1999 | WO1999008676A1 Compositions containing bergamottin for increasing the oral bioavailability of pharmaceutical agents |
| 02/25/1999 | WO1999008668A2 Combination of tyrosine kinase inhibitor and chemical castration to treat prostate cancer |
| 02/25/1999 | WO1999008636A1 Collagen-base auxiliary agent for ophthalmic surgery |
| 02/25/1999 | WO1999008539A1 Novel phytase |
| 02/25/1999 | WO1999008533A1 Central nervous system axon regeneration |
| 02/25/1999 | WO1999008522A1 Stimulation, modulation and/or inhibition of endothelial proteolytic activity and/or angiogenic activity |
| 02/25/1999 | WO1999008521A1 Treatment or prophylaxis of retinal pathology and spinal cord injury |
| 02/25/1999 | WO1999008510A1 Atrial natriuretic factor mutants and ischemic stroke |
| 02/25/1999 | WO1998054344A3 Modulators of morphogen expression and methods of identifying the same |
| 02/25/1999 | WO1998053101A3 Methods and composition to identify swine genetically resistant to f18 e. coli associated diseases |
| 02/25/1999 | WO1998053069A3 Gdnf receptors |
| 02/25/1999 | WO1998053050A3 Short peptides which selectively modulate the activity of serine/threonine kinases |
| 02/25/1999 | WO1998049321A3 Adenovirus-mediated intratumoral delivery of an angiogenesis antagonist for the treatment of tumors |
| 02/25/1999 | WO1998044088A3 Modulating the rad-nm23 interaction |
| 02/25/1999 | WO1998032017A3 Modulators of insulin receptor activity |
| 02/25/1999 | DE19736772A1 New guanidino-substituted bi:cyclic peptide compounds |
| 02/25/1999 | DE19736457A1 New super-potent human calcitonin analogues |
| 02/25/1999 | DE19735902A1 New selective adsorbent carrying peptide(s) that mimic complement C1q |
| 02/25/1999 | DE19735711A1 Insulin precursor |
| 02/25/1999 | CA2302467A1 Growth hormone secretagogues |
| 02/25/1999 | CA2301862A1 Atrial natriuretic factor mutants and ischemic stroke |
| 02/25/1999 | CA2301801A1 Elongation factor-2 kinase (ef-2 kinase) and methods of use therefor |